Binding of EBNA-1 to DNA creates a protease-resistant domain that encompasses the DNA recognition and dimerization functions

J Virol. 1992 Jun;66(6):3355-62. doi: 10.1128/JVI.66.6.3355-3362.1992.

Abstract

The Epstein-Barr virus nuclear antigen EBNA-1 is essential for replication of the viral DNA during latency. EBNA-1 binds as a dimer to palindromic recognition sequences within the plasmid origin of replication, ori-P. In this study, proteinase K susceptibility has been used to further characterize the DNA-binding domain of EBNA-1. Limited protease digestion of EBNA-1 (amino acids 408 to 641) generated a smaller DNA-binding species that had a degree of inherent protease resistance. When EBNA-1 was preincubated with a specific DNA probe, the protease resistance of the smaller binding species increased 100-fold, suggesting that the conformation of EBNA-1 changes on binding. The protease-resistant species comprised an 18-kDa polypeptide that was further cleaved at high levels of protease to 11- and 5.4-kDa products. A model of the proposed protease-resistant domain structure is presented. Constructions carrying serial, internal deletions across the 18-kDa domain were created. Each of the deletions perturbed dimerization ability and abolished DNA binding. These studies suggest that the DNA-binding and dimerization motifs of EBNA-1 lie within a conformationally discrete domain whose overall integrity is necessary for EBNA-1-DNA interaction.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antigens, Viral / drug effects
  • Antigens, Viral / metabolism*
  • DNA Mutational Analysis
  • DNA, Viral / metabolism*
  • DNA-Binding Proteins / drug effects
  • DNA-Binding Proteins / metabolism*
  • Endopeptidase K
  • Epstein-Barr Virus Nuclear Antigens
  • Herpesvirus 4, Human / drug effects
  • Herpesvirus 4, Human / metabolism*
  • Models, Biological
  • Nucleic Acid Conformation
  • Regulatory Sequences, Nucleic Acid / genetics*
  • Serine Endopeptidases / pharmacology

Substances

  • Antigens, Viral
  • DNA, Viral
  • DNA-Binding Proteins
  • Epstein-Barr Virus Nuclear Antigens
  • Serine Endopeptidases
  • Endopeptidase K